Bacteria turns plastic waste into pain relievers

Earlier this year, an unusual new way to use the main plastic addresses.

A genetically common bacteria is designed to take a plastic derived molecule and then digest To produce daily pain relieverParacetamol.

The microbe used by Stephen Wallace, a professor of chemical biotechnology at the University of Edinburgh, was the coli, known as E. Coli.

Bacteria are found in the form of a rod in the intestine of humans and animals, and it may be more familiar with it as an unpleasant wood It can make us sick.

The professor chose this automatically because some of the non -pathogenic E. Coli strains are widely used in biotechnology and engineering laboratories to test if something might work.

E. Coli is the main “WorkHorm” in the field, Professor Wallace, who was genetically designed in the laboratory to convert plastic waste into vanilla flavor and FATBERG waste from sewers to perfume.

“If you want to prove that something is possible with biology, the E.coli is the first natural stage,” he says.

Using the microbe is not only limited to the laboratory. Industrial terms, genetically engineered mobility works as a genetically engineer such as living factories that produce a variety of products of drugs such as insulin, vitality for diabetes management, to various chemicals a platform used for fuel and solvents.

But how is E. Coli as the basic pillar of biotechnology, why is it very useful and what its future might carry?

Thomas Silhavi, professor of molecular biology at Princeton University, who was doing studies in bacteria for 50 years, says Cole’s dominance stems from her role as a typical object to understand general biological principles. Its history has documented.

Other typical objects familiar include mice, fruit flies and Baker’s yeast. Yeast, like E. Coli, has become an invaluable tool in biotechnology, whether in the laboratory or industrial – but has a more complex cell structure and different applications.

E. coli was first isolated in 1885 by a German pediatrician, Theodor Ezvashsh, studying infant intestine microbes. Scientists have started to grow and easy to work with them to study basic bacterial biology.

Then in the 1940s, “Serendipity” was photographed in a large time, says Professor Silhavy.

The unpregical e

It was a historical discovery and E. Coli became the “very favorite being for everyone.”

I have seen that E. Coli continues to play a major role in many discoveries and monuments in genetics and molecular biology.

It was used to help decipher the genetic code, and in the 1970s it became the first living organism to be genetically designed when foreign DNA was introduced in it – laying the foundation for modern biotechnology.

It is also a problem with insulin production. Insulin was used from cattle and pigs to treat diabetes, but it caused allergic reactions in some patients.

But in 1978 The first artificial human insulin It is produced using E. Coli, which is a major penetration.

In 1997, it became one of the first living organisms with a complete genome sequence, making it easy to understand and treat.

Adam Vest, a professor at the University of California, San Diego, who develops microbes for industrial applications, says he estimates E. Coli for many of its useful features.

Besides the extensive knowledge of genetics and tools that make it easy to engineer, bacteria grow quickly and expected on a wide range of pillars. It is not “difficult” like some, and it can be frozen and revived without any problem, and it is unusually good in hosting foreign DNA.

“The more I work with more microorganisms, the more powerful E. Coli is.”

Cynthia Collins is a great director of Ginkgo Bioworks, a company that helps companies develop their biotechnology products, and helps them use E. Coli industrially.

Although the list of living organisms available for manufacturing is somewhat wider than it was a few decades ago-when E. Coli was the only option often-it can often be a “good choice” depending on the product, says Dr. Colines. (Even with the most intense biological engineering, E. Coli cannot produce everything).

“It is very economical; you can pump a lot,” she says, noting that if the bacteria produce something toxic to the cells, then tolerance can often be designed.

However, there are some who are wondering whether the hegemony of E. Coli has suffocated us from finding the best biotechnology solutions to our problems.

Paul Jensen, a microbiologist and engineer at the University of Michigan, studies the bacteria that live in our mouths. It has been analyzed recently Only most of the other bacteria fill for E. Coli.

His point of view is while moving forward in a more comprehensive engineering for E. Coli to do great things, there can be other microbes that do these things naturally – and better than that – do not inspect them while we are missing to benefit because they are not searched or studied.

For example, the vital problem in waste burials may lead to the appearance of microbes that started eating not only plastic but all other waste, he says. And there can be bacteria doing things – such as making cement or rubber – we didn’t even imagine. Only the bacteria that live in our mouths exceed E. Coli to endure the acid that he noticed.

“We are so deep with E. Coli that we do not achieve enough,” he says.

There are some alternatives that people work to increase options – including Vibrio Natriegens (V. NAT), which have begun to get attention as a possible competitor to E. Coli.

V. Nat was first isolated from an salt swamp in the US state of Georgia in the 1960s, but it remained largely neglected in the groups of culture and freezers until mid-2010 when it was recognized due to its super-growth-weak-growth rate of E. Coli-may be an important industrial advantage.

Buz Barsow, a biological and environmental engineer at Cornell University, is among those who develop the organism, says Boz Barresto, a biological and environmental engineer at Cornell University, is among those who develop the organism, and says its ability compared to E. Coli such as “moving from horse to car”.

The leadership of Dr. Barresto, Fox Nat is that he wants to see the microbes used to face the challenges of great sustainability – from the production of jet fuel from carbon dioxide and green electricity to rare ground minerals. He says, “Simply, E. Coli will not enter any of these visions. V. natriegens may.”

This year, his laboratory was directed by the France Evolution company, which works on tools to facilitate the researchers for its engineering in the laboratory.

Professor Feist admits that V “E. coli is difficult to replace.”